1887

Abstract

Previous analyses using transient transfection assays indicated that the promoter for the gene encoding the herpes simplex virus type 1 (HSV-1) neurovirulence protein ICP34.5 can be divided into an essential core region of approximately 80 bp and two potent upstream silencer domains corresponding to the DR2 and DR6 repeat arrays. In order to examine the potential role of transcriptional silencing during productive HSV-1 infection, recombinant viruses were generated in which wild-type or mutant ICP34.5 promoters controlling the expression of a chloramphenicol acetyltransferase reporter gene were inserted into the thymidine kinase gene of the viral genome. The intact promoter in the virus HSV- Δ1CAT exhibited delayed-early kinetics of expression that were comparable to those of the ICP34.5 gene promoter at its native site in the genome. Deletion of the core promoter domain eliminated promoter activity in the virus HSV- Δ5CAT, indicating that this region was required for expression not only in transient transfections assays but also in the context of the viral genome. However, deletion of the DR2 repeat array from the ICP34.5 promoter in the virus HSV- Δ7CAT was found to increase promoter activity only minimally at late times, and even to reduce activity at early times. Thus, in marked contrastto its behaviour in transient expression assays, the DR2 repeat array does not appear to act as a transcriptional silencer in the context of the HSV-1 genome during productive infection.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-79-3-517
1998-03-01
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/79/3/9519830.html?itemId=/content/journal/jgv/10.1099/0022-1317-79-3-517&mimeType=html&fmt=ahah

References

  1. Ackermann M., Chou J., Sarmiento M., Lerner R. A., Roizman B. 1986; Identification by antibody to a synthetic peptide of a protein specified by a diploid gene located in the terminal repeats of the L component of herpes simplex virus genome. Journal of Virology 58:843–850
    [Google Scholar]
  2. Chou J., Roizman B. 1986; The terminal a sequence of the herpes simplex virus genome contains the promoter of a gene located in the repeat sequences of the L component. Journal of Virology 57:629–637
    [Google Scholar]
  3. Chou J., Roizman B. 1994; Herpes simplex virus 1 gamma(1)34.5 gene function, which blocks the host response to infection, maps in the homologous domain of the genes expressed during growth arrest and DNA damage. Proceedings of the National Academy of Sciences, USA 91:5247–5251
    [Google Scholar]
  4. Chou J., Kern E. R., Whitley R. J., Roizman B. 1990; Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture. Science 250:1262–1266
    [Google Scholar]
  5. Chou J., Chen J. J., Gross M., Roizman B. 1995; Association of a M(r) 90 000 phosphoprotein with protein kinase PKR in cells exhibiting enhanced phosphorylation of translation initiation factor eIF-2 alpha and premature shutoff of protein synthesis after infection with gamma(1)34.5(-) mutants of herpes simplex virus 1. Proceedings of the National Academy of Sciences, USA 92:10516–10520
    [Google Scholar]
  6. Chung I. K., Soisson S. M., Muller M. T. 1995; Clustering of Sp1 sites near the promoter region of ICP34. 5 in herpes simplex virus type 1. Journal of Biochemistry, Tokyo 117:19–22
    [Google Scholar]
  7. Coen D. M., Weinheimer S. P., McKnight S. L. 1986; A genetic approach to promoter recognition during trans induction of viral gene expression. Science 234:53–59
    [Google Scholar]
  8. Deiss L. P., Chou J., Frenkel N. 1986; Functional domains within the a sequence involved in the cleavage-packaging of herpes simplex virus DNA. Journal of Virology 59:605–618
    [Google Scholar]
  9. Ebert S. N., Subramanian D., Shtrom S. S., Chung I. K., Parris D. S., Muller M. T. 1994; Association between the P170 form of human topoisomerase II and progeny viral DNA in cells infected with herpes simplex virus type 1. Journal of Virology 68:1010–1020
    [Google Scholar]
  10. Everett R. D. 1984; Trans activation of transcription by herpes virus products: requirement for two HSV-1 immediate-early polypeptides for maximum activity. EMBO Journal 3:3135–3141
    [Google Scholar]
  11. Frazier D. P., Cox D., Godshalk E. M., Schaffer P. A. 1996; Identification of cis-acting sequences in the promoter of the herpes simplex virus type 1 latency-associated transcripts required for activation by nerve growth factor and sodium butyrate in PC12 cells. Journal of Virology 70:7433–7444
    [Google Scholar]
  12. Goodart S. A., Guzowski J. F., Rice M. K., Wagner E. K. 1992; Effect of genomic location on expression of beta-galactosidase mRNA controlled by the herpes simplex virus type 1 UL38 promoter. Journal of Virology 66:2973–2981
    [Google Scholar]
  13. He B., Chou J., Liebermann D. A., Hoffman B., Roizman B. 1996; The carboxyl terminus of the murine MyD116 gene substitutes for the corresponding domain of the y1 34.5 gene of herpes simplex virus to preclude the premature shutoff of total protein synthesis in infected human cells. Journal of Virology 70:84–90
    [Google Scholar]
  14. He B., Gross M., Roizman B. 1997; The γ 34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1a to dephosphorylate the a subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proceedings of the National Academy of Sciences, USA 94:843–848
    [Google Scholar]
  15. Homa F. L., Glorioso J. C., Levine M. 1988; A specific 15-bp TATA box promoter element is required for expression of a herpes simplex virus type 1 late gene. Genes & Development 2:40–53
    [Google Scholar]
  16. Honess R. W., Roizman B. 1974; Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. Journal of Virology 14:8–19
    [Google Scholar]
  17. Huang L., Stinski M. F. 1995; Binding of cellular repressor protein or the IE2 protein to a cis-acting negative regulatory element upstream of a human cytomegalovirus early promoter. Journal of Virology 69:7612–7621
    [Google Scholar]
  18. Jones C., Zhu F., Dhanwada K. R. 1993; Analysis of a herpes simplex virus 2 fragment from the open reading frame of the large subunit of ribonucleotide reductase with transcriptional regulatory activity. DNA Cell Biology 12:127–137
    [Google Scholar]
  19. McKnight S. L., Gavis E. R. 1980; Expression of the herpes thymidine kinase gene in Xenopus laevis oocytes: an assay for the study of deletion mutants constructed in vitro . Nuclear Acids Research 8:5931–5948
    [Google Scholar]
  20. Sarisky R. T., Weber P. C. 1994; Role of anisomorphic DNA conformations in the negative regulation of a herpes simplex virus type 1 promoter. Virology 204:569–579
    [Google Scholar]
  21. Schwarzmann F., Prang N., Reichelt B., Rinkes B., Haist S., Marschall M., Wolf H. 1994; Negatively cis-acting elements in the distal part of the promoter of Epstein-Barr virus trans-activator gene BZLF1. Journal of General Virology 75:1999–2006
    [Google Scholar]
  22. Steffy K. R., Weir J. P. 1991; Mutational analysis of two herpes simplex virus type 1 late promoters. Journal of Virology 65:6454–6460
    [Google Scholar]
  23. Thrower A. R., Bullock G. C., Bissell J. E., Stinski M. F. 1996; Regulation of a human cytomegalovirus immediate early gene (US3) by a silencer/enhancer combination. Journal of Virology 70:91–100
    [Google Scholar]
  24. Varmuza S. L., Smiley J. R. 1985; Signals for site-specific cleavage of HSV DNA: maturation involves two separate cleavage events at sites distal to the recognition sequences. Cell 41:793–802
    [Google Scholar]
  25. Weber P. C., Wigdahl B. 1992; Identification of dominant-negative mutants of the herpes simplex virus type 1 immediate-early protein ICP0. Journal of Virology 66:2261–2267
    [Google Scholar]
  26. Weber P. C., Challberg M. D., Nelson N. J., Levine M., Glorioso J. C. 1988; Inversion events in the HSV-1 genome are directly mediated by the viral DNA replication machinery and lack sequence specificity. Cell 54:369–381
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-79-3-517
Loading
/content/journal/jgv/10.1099/0022-1317-79-3-517
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error